Board Meeting Details
The Board of Directors meeting is scheduled to be held on November 4, 2026. The primary agenda items include:
- Consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30, 2026
- Consideration of any other business with the permission of the Chair
The financial results will be accompanied by a Limited Review Report.
Trading Window Status
The company reiterates that the trading window for securities of the company remains closed in accordance with the Company's 'Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons.'
The trading window will reopen 48 hours after the declaration of the Unaudited Standalone Financial Results for the second quarter and half year ended September 30, 2026.